Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1148577.RAk2k5HRqdFMqJLNyWU29h6U3XovCQ_f5aSzRo0dTcs2s130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1148577.RAk2k5HRqdFMqJLNyWU29h6U3XovCQ_f5aSzRo0dTcs2s130_assertion type Assertion NP1148577.RAk2k5HRqdFMqJLNyWU29h6U3XovCQ_f5aSzRo0dTcs2s130_head.
- NP1148577.RAk2k5HRqdFMqJLNyWU29h6U3XovCQ_f5aSzRo0dTcs2s130_assertion description "[ErbB2(+) breast cancer is an aggressive breast cancer subtype generally associated with lower estrogen receptor alpha (ER?) expression and more aggressive tumor behavior compared to ER?(+)/ErbB2(-) breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1148577.RAk2k5HRqdFMqJLNyWU29h6U3XovCQ_f5aSzRo0dTcs2s130_provenance.
- NP1148577.RAk2k5HRqdFMqJLNyWU29h6U3XovCQ_f5aSzRo0dTcs2s130_assertion evidence source_evidence_literature NP1148577.RAk2k5HRqdFMqJLNyWU29h6U3XovCQ_f5aSzRo0dTcs2s130_provenance.
- NP1148577.RAk2k5HRqdFMqJLNyWU29h6U3XovCQ_f5aSzRo0dTcs2s130_assertion SIO_000772 24463007 NP1148577.RAk2k5HRqdFMqJLNyWU29h6U3XovCQ_f5aSzRo0dTcs2s130_provenance.
- NP1148577.RAk2k5HRqdFMqJLNyWU29h6U3XovCQ_f5aSzRo0dTcs2s130_assertion wasDerivedFrom befree-2016 NP1148577.RAk2k5HRqdFMqJLNyWU29h6U3XovCQ_f5aSzRo0dTcs2s130_provenance.
- NP1148577.RAk2k5HRqdFMqJLNyWU29h6U3XovCQ_f5aSzRo0dTcs2s130_assertion wasGeneratedBy ECO_0000203 NP1148577.RAk2k5HRqdFMqJLNyWU29h6U3XovCQ_f5aSzRo0dTcs2s130_provenance.